Home > Research > Publications & Outputs > Short Term Psychodynamic Psychotherapy (STPP) f...

Associated organisational unit

Electronic data

  • RPPS-2020-0013.R1_Proof_hi

    Rights statement: This is an Accepted Manuscript of an article published by Taylor & Francis in Psychoanalytic Psychotherapy on 2 Sep 2020, available online:  https://www.tandfonline.com/doi/abs/10.1080/02668734.2020.1802615

    Accepted author manuscript, 469 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License


Text available via DOI:

View graph of relations

Short Term Psychodynamic Psychotherapy (STPP) for Clients with Complex and Enduring Difficulties within NHS Mental Health Services: A Case Series

Research output: Contribution to Journal/MagazineJournal articlepeer-review

<mark>Journal publication date</mark>2/09/2020
<mark>Journal</mark>Psychoanalytic Psychotherapy
Issue number1
Number of pages19
Pages (from-to)18-36
Publication StatusPublished
<mark>Original language</mark>English


Short Term Psychodynamic Psychotherapy (STPP) has been demonstrated as an effective treatment for several mental health difficulties. However, its implementation in secondary mental health services in the National Health Service (NHS) is scarce. The aim of this study was to bridge the gap between controlled trials and practice-based evidence, by exploring an initial estimate of the therapeutic effects of this intervention as well as its safety in a secondary care NHS community mental health setting. Method: The study followed a quantitative case series design. Eight clients with complex, enduring mental health difficulties, supported by a community secondary mental health service received a course of STPP. They completed outcome measures at the start, at the end and eight-weeks following completion of therapy. Results: All participants but one completed the therapy and attendance rates were high (>75%). No adverse effects were reported. All participants but two reported improvement in the CORE-OM, BSI and the PHQ-9 and these were maintained at follow-up. Conclusions: The results suggested that STPP was a safe and acceptable intervention, that may have contributed to clinical and reliable improvement for 4 participants, non-reliable improvement for 2 and non-reliable deterioration for one participant who finished the treatment.